Tesamorelin The care checkbook
Chapter index

A guide to finding and checking care

Tesamorelin doctors: check before you choose.

This is a guide to finding and checking tesamorelin care. It has no doctor listings and does not offer visits or medicine.

Start the first check →

First, what is being offered?

A hormone is a chemical that carries messages within the body; tesamorelin copies one made in the brain.

It makes the body release more of its own growth hormone, another chemical messenger.

For adults with HIV-related lipodystrophy, tesamorelin (Egrifta SV, Egrifta WR) has US approval to reduce excess belly fat, as of September 2026.

For this guide, the letters FDA mean the US drug agency: Food and Drug Administration.

HIV is a virus; treatment for it can change how body fat is spread, a change called lipodystrophy.

The September 2026 label says tesamorelin is not meant for weight-loss care.

Check an option in this order

A search result can sound convincing. Put it through the same checks each time. Keep the answers in a note, so a warm sales pitch does not crowd them out.

The reason
What health problem is the treatment meant to address?
The person
Who would assess you, and can you check their licence?
The product
What exact medicine would be prescribed?
The plan
How would progress, new symptoms and the bill be handled?
Begin with the reason for care →

One offer deserves a hard pause

By September 2026, US law treated tesamorelin as a biologic, a type of medicine whose approval rules do not allow pharmacy-made copies.

Those US rules do not let a pharmacy make its own tesamorelin.

Compounding means making a medicine to order.

An offer of “compounded tesamorelin” is not just a price question.

Read the medicine checks →

Go straight to the check you need

Source notes for this chapter